Role of drug coated balloon angioplasty in treatment of recurrent dysfunctional arteriovenous fistulae for hemodialysis. | ||
| Fayoum University Medical Journal | ||
| Volume 13, Issue 1, January 2024, Pages 17-29 PDF (332.73 K) | ||
| Document Type: Review Articles | ||
| DOI: 10.21608/fumj.2023.238740.1266 | ||
| Authors | ||
| Abdullah Yousef Senosi* 1; Ayman Mahmoud Essawy2; Amr Abd El-Rahim Abuzaid3; Ahmed Abd El-Rahman elnagger4 | ||
| 1General Surgery. Faculty of medicine. Fayoum University. Fayoum. Egypt | ||
| 2Prof. of General Surgery Faculty of medicine, Fayoum University | ||
| 3Prof. of vascular Surgery Faculty of medicine, Cairo University | ||
| 4Lecturer of General Surgery Faculty of medicine, Fayoum University | ||
| Abstract | ||
| Background: It is generally agreed that patients receiving HD should have a permanent access such as a native AVF or AVG, however it is still a difficulty in modern medicine to keep the AVF or AVG patent. Recent research indicates that 1-year patency rates range from 62% to 68%, while 2-year rates range from 38% to 56%. Aim and objectives: evaluation of paclitaxel drug-coated balloon angioplasty for the treatment of recurrent dysfunctional arteriovenous fistulae (AVF) with respect to safety, therapeutic benefit, and patency results. Subjects and methods: Twenty patients with failed or failing AV fistulas were selected from treatment registers for a prospective case-series investigation. Results: A fixed effect model was used for analysis as no significant heterogeneity was detected. The combined result suggested no statistically significant difference between groups regarding 3-month TLPP. Forest plot of 3-month TLPP demonstrates on significant difference between groups In all, 10 studies evaluated the 6-month TLPP. After discovering substantial variability, we conducted the study using a random effect model. The combined result suggested no significant difference between groups regarding 6-month TLPP Since considerable variability was found, a random effect model was employed for the analysis. The combined result suggested no statistically significant difference between groups regarding 9-month TLPP Conclusion: Clinical and duplex assessment at 3 and 6 months after DCB angioplasty demonstrated superiority in primary patency and intervention-free survival of the target lesion without evidence of increased side events. | ||
| Keywords | ||
| drug coated balloon angioplasty; recurrent dysfunctional; arteriovenous fistulae; hemodialysis | ||
|
Statistics Article View: 86 PDF Download: 136 |
||
